Results
|
1761.
|
|
|
1762.
|
|
|
1763.
|
|
|
1764.
|
|
|
1765.
|
|
|
1766.
|
|
|
1767.
|
|
|
1768.
|
|
|
1769.
|
|
|
1770.
|
|
|
1771.
|
|
|
1772.
|
|
|
1773.
|
|
|
1774.
|
|
|
1775.
|
|
|
1776.
|
Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion. [electronic resource] by
- Sengupta, S
- Kim, K S
- Berk, M P
- Oates, R
- Escobar, P
- Belinson, J
- Li, W
- Lindner, D J
- Williams, B
- Xu, Y
Producer: 20070620
In:
Oncogene vol. 26
Availability: No items available.
|
|
1777.
|
Transgenic expression of an altered angiotensin type I AT1 receptor resulting in marked modulation of vascular type I collagen. [electronic resource] by
- Yu, Jun
- Taylor, Linda
- Rich, Celeste
- Toselli, Paul
- Stone, Philip
- Green, Daniel
- Warburton, Rod
- Hill, Nicholas
- Goldstein, Ronald
- Polgar, Peter
Producer: 20120402
In:
Journal of cellular physiology vol. 227
Availability: No items available.
|
|
1778.
|
|
|
1779.
|
|
|
1780.
|
Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis. [electronic resource] by
- Sales, K U
- Friis, S
- Konkel, J E
- Godiksen, S
- Hatakeyama, M
- Hansen, K K
- Rogatto, S R
- Szabo, R
- Vogel, L K
- Chen, W
- Gutkind, J S
- Bugge, T H
Producer: 20150422
In:
Oncogene vol. 34
Availability: No items available.
|